CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Abliva AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Abliva AB
Medicon Village, Scheeletorget 1
Phone: +46 462756220p:+46 462756220 LUND, 223 81  Sweden Ticker: ABLIABLI
Business Summary
Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board DavidLaskow-Pooley 69 1/1/2021 4/28/2016
Chief Executive Officer EllenDonnelly 49 2/3/2021 2/3/2021
Deputy Chief Executive Officer, Chief Financial Officer, Secretary Catharina J.Johansson 56 1/1/2022 12/1/2013
7 additional Officers and Directors records available in full report.

Business Names
Business Name
0QDU
ABLI
NeuroVive Pharmaceutical AB
5 additional Business Names available in full report.

General Information
Number of Employees: 6 (As of 12/31/2022)
Outstanding Shares: 1,056,299,165 (As of 12/31/2023)
Shareholders: 13,231
Stock Exchange: STO
Fax Number: +46 468888348


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 22, 2024